Faecal diversion in the management of perianal Crohn's disease

Colorectal Disease

Volumn 13, Issue 2, 2011, Pages 171-176

  Hong, M K H ^a   Craig Lynch, A ^b,c,d   Bell, S ^a   Woods, R J ^a   Keck, J O ^a   Johnston, M J ^a   Heriot, A G ^a,c,d  

^a ST VINCENT S HOSPITAL   (Australia)

^b BOX HILL HOSPITAL   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Colostomy; Crohn's disease; Ileostomy; Infliximab; Rectal fistula; Rectovaginal fistula

Indexed keywords

INFLIXIMAB;

ADULT; AGED; ARTICLE; BIOLOGICAL THERAPY; CLINICAL ARTICLE; COLON CROHN DISEASE; DEMOGRAPHY; FAECAL DIVERSION; FEMALE; FOLLOW UP; HUMAN; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROCTOCOLECTOMY; SURGICAL APPROACH; TREATMENT DURATION;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANUS DISEASES; COLOSTOMY; CROHN DISEASE; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL AGENTS; HUMANS; MALE; MIDDLE AGED; PROCTOCOLECTOMY, RESTORATIVE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 78751689193     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2009.02092.x     Document Type: Article

References (28)

1. Talbot C, Sagar PM, Johnston MJ, Finan PJ, Burke D. Infliximab in the surgical management of complex fistulating anal Crohn's disease. Colorectal Dis 2005; 7: 164-8.
2. Platell C, Mackay J, Collopy B, Fink R, Ryan P, Woods R. Anal pathology in patients with Crohn's disease. Aust N Z J Surg 1996; 66: 5-9.
3. Solomon MJ. Fistulae and abscesses in symptomatic perianal Crohn's disease. Int J Colorectal Dis 1996; 11: 222-6.
4. Williamson PR, Hellinger MD, Larach SW, Ferrara A. Twenty-year review of the surgical management of perianal Crohn's disease. Dis Colon Rectum 1995; 38: 389-92.
5. Yamamoto T, Allan RN, Keighley MR. Effect of fecal diversion alone on perianal Crohn's disease. World J Surg 2000; 24: 1258-62; discussion 62-3.
6. Regimbeau JM, Panis Y, Cazaban L, Pocard M, Bouhnik Y, Matuchansky C, Valleur P. Long-term results of faecal diversion for refractory perianal Crohn's disease. Colorectal Dis 2001; 3: 232-7.
7. Mueller MH, Geis M, Glatzle J, Kasparek M, Meile T, Jehle EC, Kreis ME, Zittel TT. Risk of fecal diversion in complicated perianal Crohn's disease. J Gastrointest Surg 2007; 11: 529-37.
8. Galandiuk S, Kimberling J, Al-Mishlab TG, Stromberg AJ. Perianal Crohn disease: predictors of need for permanent diversion. Ann Surg 2005; 241: 796-801; discussion 801-2.
9. McNamara DA, Brophy S, Hyland JM. Perianal Crohn's disease and infliximab therapy. Surgeon 2004; 2: 258-63.
10. Panes J, Gomollon F, Taxonera C, Hinojosa J, Clofent J, Nos P. Crohn's disease: a review of current treatment with a focus on biologics. Drugs 2007; 67: 2511-37.
11. Hanauer SB, Feagan BG, Lichtenstein GR et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 2002; 359: 1541-9.
12. Present DH, Rutgeerts P, Targan S et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 1999; 340: 1398-405.
13. Sands BE, Anderson FH, Bernstein CN et al. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med 2004; 350: 876-85.
14. Grant DR, Cohen Z, McLeod RS. Loop ileostomy for anorectal Crohn's disease. Can J Surg 1986; 29: 32-5.
15. Harper PH, Kettlewell MG, Lee EC. The effect of split ileostomy on perianal Crohn's disease. Br J Surg 1982; 69: 608-10.
16. Makowiec F, Jehle EC, Starlinger M. Clinical course of perianal fistulas in Crohn's disease. Gut 1995; 37: 696-701.
17. Buchmann P, Keighley MR, Allan RN, Thompson H, Alexander-Williams J. Natural history of perianal Crohn's disease. Ten year follow-up: a plea for conservatism. Am J Surg 1980; 140: 642-4.
18. Williams JG, Rothenberger DA, Nemer FD, Goldberg SM. Fistula-in-ano in Crohn's disease. Results of aggressive surgical treatment. Dis Colon Rectum 1991; 34: 378-84.
19. Rutgeerts P. Review article: treatment of perianal fistulizing Crohn's disease. Aliment Pharmacol Ther 2004; 20(Suppl 4): 106-10.
20. Targan SR, Hanauer SB, van Deventer SJ, Mayer L, Present DH, Braakman T, DeWoody KL, Schaible TF, Rutgeerts PJ. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 1997; 337: 1029-35.
21. Van Assche G, Vanbeckevoort D, Bielen D et al. Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease. Am J Gastroenterol 2003; 98: 332-9.
22. Bell SJ, Halligan S, Windsor AC, Williams AB, Wiesel P, Kamm MA. Response of fistulating Crohn's disease to infliximab treatment assessed by magnetic resonance imaging. Aliment Pharmacol Ther 2003; 17: 387-93.
23. Gaertner WB, Decanini A, Mellgren A, Lowry AC, Goldberg SM, Madoff RD, Spencer MP. Does infliximab infusion impact results of operative treatment for Crohn's perianal fistulas? Dis Colon Rectum 2007; 50: 1754-60.
24. Topstad DR, Panaccione R, Heine JA, Johnson DR, MacLean AR, Buie WD. Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience. Dis Colon Rectum 2003; 46: 577-83.
25. Hyder SA, Travis SP, Jewell DP, Mortensen NJMcC, George BD. Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment. Dis Colon Rectum 2006; 49: 1837-41.
26. Kasparek MS, Glatzle J, Temeltcheva T, Mueller MH, Koenigsrainer A, Kreis ME. Long-term quality of life in patients with Crohn's disease and perianal fistulas: influence of fecal diversion. Dis Colon Rectum 2007; 50: 2067-74.
27. Güenaga K, Lustosa S, Saad S, Saconato H, Matos D. Ileostomy or colostomy for temporary decompression of colorectal anastomosis. Cochrane Database Syst Rev 2007; CD004647.
28. Regueiro M, Schraut W, Baidoo L, Kip KE, Sepulveda AR, Pesci M, Harrison J, Plevy SE. Infliximab prevents Crohn's disease recurrence after ileal resection. Gastroenterology 2009; 136: 441-50.